Novo Nordisk has partnered with India's Emcure Pharmaceuticals to exclusively distribute and market its weight-loss drug ...

Emcure becomes first Indian company to commercialise semaglutide 2.4 mg, the second brand of Wegovy®, in India.

The partnership comes just five months after Wegovy debuted in India, and signals Novo Nordisk’s intent to scale access ...

As part of the agreement, Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing ...

Novo Nordisk India has teamed up with Emcure Pharmaceuticals to distribute and market the weight-loss drug, Poviztra, a second brand of Wegovy, across India.

Leading global healthcare company, Novo Nordisk, has presented a new data from the recently conducted trial that explored a ...

The Nifty is coming on the back of two straight weekly losses in what could be the final week of this quarter's earnings ...